bufalin has been researched along with Hypoxia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Li, Y; Liu, C; Ma, S; Shang, J; Sun, Y; Wu, H; Yin, P; Yuan, Z; Zhan, Y | 1 |
1 other study(ies) available for bufalin and Hypoxia
| Article | Year |
|---|---|
Bufalin exacerbates Photodynamic therapy of colorectal cancer by targeting SRC-3/HIF-1α pathway.
Topics: Animals; Bufanolides; Cell Line, Tumor; Colorectal Neoplasms; Hypoxia; Mice; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents | 2022 |